Skip to content

Impact on the Length of Stay in Incentive Spirometry and Pain in the Decompensation of Sickle Cell Disease: .

Incentive Spirometry and Pain in the Decompensation of Sickle Cell Disease: Impact on the Length of Stay. Prospective Observational Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04041180
Acronym
SPIDO
Enrollment
25
Registered
2019-08-01
Start date
2018-11-06
Completion date
2019-04-06
Last updated
2019-08-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pediatric, Sickle Cell Disease

Keywords

Sickle cell disease, incentive spirometry, pain, children

Brief summary

In this prospective observational study among sickle cell children aged 7 to 17 years, who face many experience of pain, pain will be assessed during incentive spirometry sessions. Then a relation between, inspiratory volume, pain and the length of hospital stay will be identified . Currently, there is no scientific data regarding the correlation between acute pain during vaso-occlusive crisis, incentive spirometry and the impact on length of hospital stay. In fact, physiotherapist experience's in the pediatric department suggests that the pain expressed by the child is not always correlated with inspiratory capacity. The absence of pain is one of the reasons for hospital discharge after decompensation in patients with sickle cell disease. However, no scientific study has linked incentive spirometry, pain and length of hospital stay. Investigator assume that these children underestimate the real pain and its impact on breathing pattern, and presume that the maximal inspiratory volume during spirometry sessions will be a better reflect of pain than standard pain scale. The aim of this study is to show that inspiratory volume would be a better indicator of discharge from hospitalization than actual pain scales.

Interventions

None listed

Sponsors

Centre Hospitalier Régional d'Orléans
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
7 Years to 17 Years
Healthy volunteers
No

Inclusion criteria

* Sickle cell children aged 7 to 17 admitted to the pediatric ward * Children receiving respiratory physiotherapy sessions under medical prescription * Children hospitalized for more than 24 hours at the CHRO and benefiting from more than one physiotherapy session. * Absence of opposition of one of the parents to the participation of their child in the study * Absence of opposition of children able to understand the study Non inclusion Criteria: * Sickle cell children under the age of 7 or over 17 * Children with mental deficits * Non-French-speaking parents * Children receiving only one physiotherapy session and being hospitalized within 24 hours

Design outcomes

Primary

MeasureTime frame
Number of day staying in the pediatric ward according to the maximal inspiratory capacities during incentive spirometry sessions.throught study completion, an overage of 24hours

Secondary

MeasureTime frame
Correlation between pain level and maximal inspiratory capacity during incentive spirometry sessions.throught study completion, an overage of 24hours
Correlation between the maximum inspiratory volume achieved during incentive spirometry and children's mobility (attitude and mobility items according to the EVENDOL scale).throught study completion, an overage of 24hours
Correlation between the use of analgesic strategies and the inspiratory volume related to patients' size and agethrought study completion, an overage of 24hours

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026